School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Wiley Interdiscip Rev Syst Biol Med. 2018 Mar;10(2). doi: 10.1002/wsbm.1405. Epub 2017 Sep 28.
Small molecules have many important roles across the tree of life: they regulate processes from metabolism to transcription, they enable signaling within and between species, and they serve as the biochemical building blocks for cells. They also represent valuable phenotypic endpoints that are promising for use as biomarkers of disease states. In the context of engineering cell-based therapeutics, they hold particularly great promise for enabling finer control over the therapeutic cells and allowing them to be responsive to extracellular cues. The natural signaling and regulatory functions of small molecules can be harnessed and rewired to control cell activity and delivery of therapeutic payloads, potentially increasing efficacy while decreasing toxicity. To that end, this review considers small molecule-mediated regulation and signaling in bacteria. We first discuss some of the most prominent applications and aspirations for responsive cell-based therapeutics. We then describe the transport, signaling, and regulation associated with three classes of molecules that may be exploited in the engineering of therapeutic bacteria: amino acids, fatty acids, and quorum-sensing signaling molecules. We also present examples of existing engineering efforts to generate cells that sense and respond to levels of different small molecules. Finally, we discuss future directions for how small molecule-mediated regulation could be harnessed for therapeutic applications, as well as some critical considerations for the ultimate success of such endeavors. WIREs Syst Biol Med 2018, 10:e1405. doi: 10.1002/wsbm.1405 This article is categorized under: Biological Mechanisms > Cell Signaling Biological Mechanisms > Metabolism Translational, Genomic, and Systems Medicine > Therapeutic Methods.
它们调节代谢到转录等过程,使物种内和物种间的信号传递成为可能,并作为细胞的生化构建块。它们还代表着有价值的表型终点,有望作为疾病状态的生物标志物。在基于细胞的治疗工程学的背景下,它们为更精细地控制治疗细胞并使它们能够对外界线索做出反应提供了特别大的希望。小分子的天然信号和调节功能可以被利用和重新布线,以控制细胞活性和治疗有效载荷的传递,从而有可能提高疗效,同时降低毒性。为此,本综述考虑了小分子介导的细菌中的调节和信号转导。我们首先讨论了一些最突出的应用和对响应型基于细胞的治疗的渴望。然后,我们描述了与三类可能在治疗细菌的工程中利用的分子相关的运输、信号传递和调节:氨基酸、脂肪酸和群体感应信号分子。我们还介绍了一些现有的工程努力的例子,这些努力旨在生成能够感知和响应不同小分子水平的细胞。最后,我们讨论了如何利用小分子介导的调节来进行治疗应用的未来方向,以及这些努力最终取得成功的一些关键考虑因素。